Antagonist activity at mouse NR1/NR2B receptor D101A mutant expressed in Xenopus laevis oocytes assessed as inhibition of glutamate/glycine-induced current by two electrode voltage clamp method
Antagonist activity at GluN2B/NMDA in FVB mouse CA1 pyramidal neurons assessed as reduction in NMDA-mediated inward current at 10 uM measured for 5 mins by whole-cell patch clamp assay in presence of glycine and tetrodotoxin
Antagonist activity at NMDA receptor GluN2B subunit in FVB mouse CA1 pyramidal neurons assessed as decrease in EPSC amplitude at holding potential of -60 mV at 100 nM measured at 5 mins by patch clamp electrophysiological assay in presence of Mg2+ free ACSF containing CNQX, glycine, bicuculline relative to control
Antagonist activity at NMDA receptor GluN2B subunit in FVB mouse CA1 pyramidal neurons assessed as decrease in EPSC amplitude at holding potential of -60 mV at 6 uM measured at 5 mins by patch clamp electrophysiological assay in presence of Mg2+ free ACSF containing CNQX, glycine, bicuculline relative to control
Modulation of NMDA receptor GluN2B subunit in FVB mouse CA1 pyramidal neurons assessed as decrease in EPSC amplitude at holding potential of -60 mV at 10 uM measured at 5 mins by patch clamp electrophysiological assay in presence of Mg2+ free ACSF containing CNQX, glycine, bicuculline relative to control
Modulation of NMDA receptor GluN2B subunit in FVB mouse CA1 pyramidal neurons assessed as increase in EPSC amplitude at holding potential of -60 mV at 10 uM measured at 5 mins by patch clamp electrophysiological assay in presence of Mg2+ free ACSF containing CNQX, glycine, bicuculline relative to control
Antagonist activity at NMDA receptor GluN2B subunit in FVB mouse CA1 pyramidal neurons assessed as decrease in EPSC amplitude at holding potential of -60 mV at 50 uM measured at 5 mins by patch clamp electrophysiological assay in presence of Mg2+ free ACSF containing CNQX, glycine, bicuculline relative to control
Antagonist activity at NMDA receptor GluN2B subunit in FVB mouse CA1 pyramidal neurons assessed as reversible reduction of excitatory post synaptic current amplitude at 50 nM at holding potential of -60 mV measured for 5 mins by patch clamp technique in presence of Mg2+free ACSF relative to control
Antagonist activity at mouse NR2B expressed in Hek293 cells co-expressing mouse NR1 assessed as inhibition of glutamic acid/glycine-induced intracellular Ca2+ levels measured after 1 day post induction by Fluo-3/AM dye-based fluorescence assay
Antagonist activity at mouse NR2B receptor expressed in HEK293 cells co-expressing NR1 subunit assessed as reduction in glutamic acid/glycine-induced calcium ion influx by fluorescence based assay